Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock

Clinical trial NCT02730624 · COMPLETED

Trial details

NCT number: NCT02730624
Sponsor: Sutep Jaruratanasirikul
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Early Phase of Severe Sepsis and Septic Shock

Start date: 2014-03-01
Primary completion: 2016-05-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.